Breast Cancer
Reports outline breast cancer study results from Genentech, Inc.
Published in Anti-Infectives Week, March 22nd, 2010
"Patterns of breast cancer care continue to be amended because of the more frequent use of anthracyclines and taxanes in earlier lines of therapy (particularly in the adjuvant setting) and the emergence of multidrug resistance. When treating women with recurrent or metastatic breast cancer that is resistant to anthracyclines and taxanes, nurses have a unique opportunity to foster a sense of hope by helping patients understand available treatment options and what to expect during therapy," scientists writing in the Clinical Journal of Oncology Nursing report.
"This article presents information on the use of an epothilone agent, ixabepilone (Ixempra ®,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2010-03-22)
More Articles from Anti-Infectives Week
- Antiretrovirals
Study findings from University of Barcelona provide new insights into antiretrovirals - Apoptosis
Research on apoptosis described by H. Chen and colleagues - Drug Resistance
New drug resistance study findings have been reported by scientists at Nagoya University, Medical Department - Drug Resistance
New findings from Central Hospital in the area of drug resistance published - Drug Resistance
Reports from University of Helsinki add new data to research in drug resistance - Drug Resistance
Research from Niigata University provides new data on drug resistance - More from this issue of Anti-Infectives Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
